Jacob Ezell, MD
Pain Medicine · Cleveland, OHNPI 1295129369
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (49.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Medtronic at 37.4% of the total. Reporting peaked in 2020 at $6,607 and has fallen 99.7% since, to $22 in 2025.
Across 82 payments — averaging $142.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$4K
- Nevro Corp.$2K
- Vertos Medical, Inc.$546
- Boston Scientific$425
- Saluda Medical Americas, Inc.$212
- plus $455 from 5 others
What the payments were for
- Consulting fees$1001%
- Grants$5,80050%
- Travel & lodging$1,72415%
- Food & beverage$3,97134%
- Education$801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 9 | $4,366 |
| Abbott | 26 | $3,787 |
| Nevro Corp. | 20 | $1,884 |
| Vertos Medical, Inc. | 8 | $546 |
| Boston Scientific | 8 | $425 |
| Saluda Medical Americas, Inc. | 1 | $212 |
| Nalu Medical, Inc. | 5 | $139 |
| Globus Medical | 1 | $121 |
| Comsort, Inc | 1 | $100 |
| Trice Medical, Inc. | 2 | $71 |
| Lundbeck LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$4,000
- Senza Spinal Cord Stimulation System$1,066
- PROCLAIM$669
- Proclaim Family of SCS IPGs$607
- Senza$281
- INTELLIS ADAPTIVESTIM$237
- mild Device Kit$215
- Evoke$212
- ELSA ATP$121
- Proclaim IPG$102
- BRIDION$100
How this compares
$11,674 in reported general payments places this provider in the 85th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 145 | $5,138 |
| Gabapentin | 214 | $3,615 |
| Duloxetine Hcl | 48 | $1,158 |
| Tizanidine Hcl | 92 | $772 |
| Baclofen | 25 | $532 |
| Cyclobenzaprine Hcl | 19 | $305 |
| Meloxicam | 56 | $229 |
| Amitriptyline Hcl | 18 | $201 |
| Celecoxib | 14 | $186 |
| Nortriptyline Hcl | 21 | $143 |
| Methocarbamol | 13 | $140 |
| Methylprednisolone | 15 | $105 |
| Tramadol Hcl | 16 | $68 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Cleveland
- Nagy MekhailCleveland$511K
- Robert BolashCleveland$154K
- Aman UpadhyayCleveland$40K
- Salim HayekCleveland$34K
- Trishul KapoorCleveland$33K
- Edward CovingtonCleveland$25K
- Jianguo ChengCleveland$23K
- Kush GoyalCleveland$22K
- Jijun XuCleveland$10K
- Riad LahamCleveland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.